Supernus appoints Victor Vaughn as SVP sales
ROCKVILLE, Md. — A maker of drugs for epilepsy has appointed a new executive.
Supernus Pharmaceuticals announced the appointment of Victor Vaughn as SVP sales, a position in which he will be responsible for leading all the company’s sales activities.
"Victor has an outstanding track record of success in building sales organizations and launching specialty products specifically in the epilepsy and ADHD areas," Supernus CEO Jack Khattar said. "He led the Shire sales organization for 13 years with sales reaching more than $1 billion behind products, including Carbatrol in epilepsy and Adderall XR in ADHD."
Supernus markets the drug Oxtellar XR (oxcarbazepine) for epilepsy and has tentative approval to market another epilepsy drug, Trokendi XR (topiramate).
The Locking Cap wins award, introduces new look
LINCOLN, Calif. — A drug-security product has won a drug-abuse prevention award.
The Locking Cap was named as one of the "Top 5 Technologies to Reduce Prescription Drug Abuse" by the Center for Lawful Access and Abuse Deterrence.
The cap is a four-digit combination-locking lid for prescription medication bottles. The maker of the cap, Cap-n-Lock, launched an updated version of the cap at the beginning of the year to attract the attention of shoppers.
"We are certain that our new look will have a greater impact on the customer, thus promoting our cause to secure medications and protect adolescents from accessing them," Locking Cap creator Joseph Simpson said.
GPhA appoints Claire Sheahan as VP communications
WASHINGTON — The Generic Pharmaceutical Association has appointed a new officer to head its communications, the industry trade group said Tuesday.
The GPhA announced the appointment of Claire Sheahan as VP communications, effective Jan. 22. Sheahan previously worked as SVP and partner of communications firm Fleishman-Hillard, leading the firm’s Washington-based healthcare practice.
"We are so pleased to welcome Claire to the GPhA team," GPhA president and CEO Ralph Neas said. "Her exceptional background, especially the successful public international initiatives she has directed, here in Washington, nationally and globally, will be indispensable to our organization."